s Is This Fraud Too Big Even For 60 Minutes? | I2P: Information to Pharmacists - Archive
Publication Date 01/07/2014         Volume. 6 No. 6   
Information to Pharmacists

Editorial

From the desk of the editor

Welcome to the July 2014 homepage edition of i2P (Information to Pharmacists) E-Magazine.
At the commencement of 2014 i2P focused on the need for the entire profession of pharmacy and its associated industry supports to undergo a renewal and regeneration.
We are now half-way through this year and it is quite apparent that pharmacy leaders do not yet have a cohesive and clear sense of direction.
Maybe the new initiative by Woolworths to deliver clinical service through young pharmacists and nurses may sharpen their focus.
If not, community pharmacy can look forward to losing a substantial and profitable market share of the clinical services market.
Who would you blame when that happens?
But I have to admit there is some effort, even though the results are but meagre.
In this edition of i2P we focus on the need for research about community pharmacy, the lack of activity from practicing pharmacists and when some research is delivered, a disconnect appears in its interpretation and implementation.

read more
open full screen

Recent Comments

Click here to read...

News Flash

Newsflash Updates for July 2014

Newsflash Updates

Regular weekly updates that supplement the regular monthly homepage edition of i2P. 
Access and click on the title links that are illustrated

Comments: 1

read more
open full screen

Feature Contribution

Woolworths Pharmacy - Getting One Stage Closer

Neil Johnston

It started with “tablet” computers deployed on shelves inside the retailer Coles, specifically to provide information to consumers relating to pain management and the sale of strong analgesics.
This development was reported in i2P under the title Coles Pharmacy Expansion and the Arid PGA Landscape”
In that article we reported that qualified information was a missing link that had come out of Coles market research as the reason to why it had not succeeded in dominating the pain market.
Of course, Woolworths was working on the same problem at the same time and had come up with a better solution - real people with good information.

Comments: 5

read more
open full screen

Intensive Exposition without crossing over with a supermarket

Fiona Sartoretto Verna AIAPP

Editor's Note: The understanding of a pharmacy's presentation through the research that goes into the design of fixtures and fittings that highlight displays, is a never-ending component of pharmacy marketing.
Over the past decade, Australian pharmacy shop presentations have fallen behind in standards of excellence.
It does not take rocket science - you just have to open your eyes.
Recently, our two major supermarkets, Woolworths and Coles, have entered into the field of drug and condition information provision - right into the heartland of Australian Pharmacy.

read more
open full screen

The sure way to drive business away

Gerald Quigley

I attended the Pregnancy, Baby and Children’s Expo in Brisbane recently.
What an eye and ear opening event that was!
Young Mums, mature Mums, partners of all ages, grandparents and friends……...many asking about health issues and seeking reassurances that they were doing the right thing.

Comments: 1

read more
open full screen

‘Marketing Based Medicine’ – how bad is it?

Baz Bardoe

It should be the scandal of the century.
It potentially affects the health of almost everyone.
Healthcare providers and consumers alike should be up in arms. But apart from coverage in a few credible news sources the problem of ‘Marketing Based Medicine,’ as psychiatrist Dr Peter Parry terms it, hasn’t as yet generated the kind of universal outrage one might expect.

read more
open full screen

Community Pharmacy Research - Are You Involved?

Mark Coleman

Government funding is always scarce and restricted.
If you are ever going to be a recipient of government funds you will need to fortify any application with evidence.
From a government perspective, this minimises risk.
I must admit that while I see evidence of research projects being managed by the PGA, I rarely see community pharmacists individually and actively engaged in the type of research that would further their own aims and objectives (and survival).

read more
open full screen

Organisational Amnesia and the Lack of a Curator Inhibits Cultural Progress

Neil Johnston

Most of us leave a tremendous impact on pharmacies we work for (as proprietors, managers, contractors or employees)—in ways we’re not even aware of.
But organisational memories are often all too short, and without a central way to record that impact and capture the knowledge and individual contributions, they become lost to time.
It is ironic that technology has provided us with phenomenal tools for communication and connection, but much of it has also sped up our work lives and made knowledge and memory at work much more ephemeral.

read more
open full screen

Academics on the payroll: the advertising you don't see

Staff Writer

This article was first published in The Conversation and was written by Wendy Lipworth, University of Sydney and Ian Kerridge, University of Sydney
In the endless drive to get people’s attention, advertising is going ‘native’, creeping in to places formerly reserved for editorial content. In this Native Advertising series we find out what it looks like, if readers can tell the difference, and more importantly, whether they care.
i2P has republished the article as it supports our own independent and ongoing investigations on how drug companies are involved in marketing-based medicine rather than evidence-based medicine.

read more
open full screen

I’ve been thinking about admitting wrong.

Mark Neuenschwander

Editor's Note: This is an early article by Mark Neuenschwander we have republished after the soul-searching surrounding a recent Australian dispensing error involving methotrexate.
Hmm. There’s more than one way you could take that, huh? Like Someday when I get around to it (I’m not sure) I may admit that I was wrong about something. Actually, I’ve been thinking about the concept of admitting wrong. So don’t get your hopes up. No juicy confessions this month except that I wish it were easier for me to admit when I have been wrong or made a mistake.
Brian Goldman, an ER physician from Toronto, is host of the award-winning White Coat, Black Art on CBC Radio and slated to deliver the keynote at The unSUMMIT for Bedside Barcoding in Anaheim this May. His TED lecture, entitled, “Doctors make mistakes. Can we talk about it?” had already been viewed by 386,072 others before I watched it last week.

read more
open full screen

Dispensing errors – a ripple effect of damage

Kay Dunkley - BPharm, Grad Dip Hosp Pharm, Grad Dip Health Admin, MPS, MSHPA

Most readers will be aware of recent publicity relating to dispensing errors and in particular to deaths caused by methotrexate being incorrectly packed in dose administration aids.
The Pharmacy Board of Australia (PBA), in its Communique of 13 June 2014, described a methotrexate packing error leading to the death of a patient and noted “extra vigilance is required to be exercised by pharmacists with these drugs”.
This same case was reported by A Current Affair (ACA) in its program on Friday 20 June
http://aca.ninemsn.com.au/article/8863098/prescription-drug-warning

read more
open full screen

Take a vacation from your vocation

Harvey Mackay

Have you ever had one of those days when all you could think was, “Gosh, do I need a vacation.”
Of course you have – because all work and no play aren’t good for anyone.
A vacation doesn’t have to be two weeks on a tropical island, or even a long weekend at the beach. 
A vacation just means taking a break from your everyday activities. 
A change of pace. 
It doesn’t matter where.
Everyone needs a vacation to rejuvenate mentally and physically. 
But did you also know that you can help boost our economy by taking some days off? 
Call it your personal stimulus package.

read more
open full screen

Explainer: what is peer review?

Staff Writer

This article was first published in the Conversation. It caught our eye because "peer review" it is one of the standards for evidence-based medicines that has also been corrupted by global pharma.
The article is republished by i2P as part of its ongoing investigation into scientific fraud and was writtenby Andre Spicer, City University London and Thomas Roulet, University of Oxford
We’ve all heard the phrase “peer review” as giving credence to research and scholarly papers, but what does it actually mean?
How does it work?
Peer review is one of the gold standards of science. It’s a process where scientists (“peers”) evaluate the quality of other scientists' work. By doing this, they aim to ensure the work is rigorous, coherent, uses past research and adds to what we already knew.
Most scientific journals, conferences and grant applications have some sort of peer review system. In most cases it is “double blind” peer review. This means evaluators do not know the author(s), and the author(s) do not know the identity of the evaluators.
The intention behind this system is to ensure evaluation is not biased.
The more prestigious the journal, conference, or grant, the more demanding will be the review process, and the more likely the rejection. This prestige is why these papers tend to be more read and more cited.

read more
open full screen

Dentists from the dark side?

Loretta Marron OAM BSc

While dining out with an elderly friend, I noticed that he kept his false tooth plate in his shirt pocket. He had recently had seven amalgam-filled teeth removed, because he believed that their toxins were making him sick; but his new plate was uncomfortable. He had been treated by an 'holistic dentist'. Claiming to offer a "safe and healthier alternative" to conventional dentistry, are they committed to our overall health and wellbeing or are they promoting unjustified fear, unnecessarily extracting teeth and wasting our money?

read more
open full screen

Planning for Profit in 2015 – Your key to Business Success

Chris Foster

We are now entering a new financial year and it’s a great time to reflect on last year and highlight those things that went well and those that may have impacted negatively in the pursuit of your goals.
It's also a great to spend some time re-evaluating your personal and business short, medium and long term goals in the light of events over the last year.
The achievement of your goals will in many cases be dependent on setting and aspiring to specific financial targets. It's important that recognise that many of your personal goals will require you to generate sufficient business profits to fund those aspirations

read more
open full screen

ReWalk™ Personal Exoskeleton System Cleared by FDA for Home Use

Staff Writer

Exoskeleton leader ReWalk Robotics announced today that the U.S. Food and Drug Administration has cleared the company’s ReWalk Personal System for use at home and in the community.
ReWalk is a wearable robotic exoskeleton that provides powered hip and knee motion to enable individuals with Spinal Cord Injury (SCI) to stand upright and walk.
ReWalk, the only exoskeleton with FDA clearance via clinical studies and extensive performance testing for personal use, is now available throughout the United States.

read more
open full screen

Attracting and Retaining Great People

Barry Urquhart

Welcome to the new financial year in Australia.
For many in business the past year has been described as a challenging period.
Adjectives are a key feature of the English language.  In the business lexicon their use can be, and often is evocative and stimulate creative images.  But they can also contribute to inexact, emotional perceptions.
Throughout the financial pages of newspapers and business magazines adjectives abound.
References to “hot” money draw attention and comment.  The recent wave of funds from Chinese investors, keen to remove their wealth from the jurisdiction and control of government regulations is creating a potential property bubble in Australia.

read more
open full screen

Updating Your Values - Extending Your Culture

Neil Johnston

Pharmacy culture is dormant.
Being comprised of values, unless each value is continually addressed, updated or deleted, entire organisations can stagnate (or entire professions such as the pharmacy profession).
Good values offer a strong sense of security, knowing that if you operate within the boundaries of your values, you will succeed in your endeavours.

read more
open full screen

Evidence-based medicine is broken. Why we need data and technology to fix it

Staff Writer

The following article is reprinted from The Conversation and forms up part of our library collection on evidence-based medicines.
At i2P we also believe that the current model of evidence is so fractured it will never be able to be repaired.
All that can happen is that health professionals should independently test and verify through their own investigations what evidence exists to prescribe a medicine of any potency.
Health professionals that have patients (such as pharmacists) are ideally placed to observe and record the efficacy for medicines.
All else should confine their criticisms to their evidence of the actual evidence published.
If there are holes in it then share that evidence with the rest of the world.
Otherwise, do not be in such a hurry to criticise professions that have good experience and judgement to make a good choice on behalf of their patients, simply because good evidence has not caught up with reality.

read more
open full screen

Laropiprant is the Bad One; Niacin is/was/will always be the Good One

Staff Writer

Orthomolecular Medicine News Service, July 25, 2014
Laropiprant is the Bad One; Niacin is/was/will always be the Good One
by W. Todd Penberthy, PhD

(OMNS July 25, 2014) Niacin has been used for over 60 years in tens of thousands of patients with tremendously favorable therapeutic benefit (Carlson 2005).
In the first-person NY Times best seller, "8 Weeks to a Cure for Cholesterol," the author describes his journey from being a walking heart attack time bomb to a becoming a healthy individual.
He hails high-dose niacin as the one treatment that did more to correct his poor lipid profile than any other (Kowalski 2001).

read more
open full screen

Culture Drive & Pharmacy Renewal

Neil Johnston

Deep within all of us we have a core set of values and beliefs that create the standards of behaviour that we align with when we set a particular direction in life.
Directions may change many times over a lifetime, but with life experiences and maturity values may increase in number or gain greater depth.
All of this is embraced under one word – “culture”.
When a business is born it will only develop if it has a sound culture, and the values that comprise that culture are initially inherent in the business founder.
A sound business culture equates to a successful business and that success is often expressed in the term “goodwill” which can be eventually translated to a dollar value.

read more
open full screen

ReWalk™ Personal Exoskeleton System Cleared by FDA for Home Use

Staff Writer

Exoskeleton leader ReWalk Robotics announced today that the U.S. Food and Drug Administration has cleared the company’s ReWalk Personal System for use at home and in the community.
ReWalk is a wearable robotic exoskeleton that provides powered hip and knee motion to enable individuals with Spinal Cord Injury (SCI) to stand upright and walk.
ReWalk, the only exoskeleton with FDA clearance via clinical studies and extensive performance testing for personal use, is now available throughout the United States.

read more
open full screen

Pharmacy 2014 - Pharmacy Management Conference

Neil Johnston

The brave new world of health and wellness is not the enemy of Pharmacy, it is its champion.
Australian futurist, Morris Miselowski, one of the world's leading business visionaries, will present the Opening Keynote address on Pharmacy's Future in the new Health and Wellness Landscape at 2.00pm on Wednesday July 30.
Morris believes the key to better health care could already be in your pocket, with doctors soon set to prescribe iPhone apps, instead of pills.
Technology will revolutionise the health industry - a paradigm shift from healthcare to personal wellness.
Health and wellness applications on smartphones are already big news, and are dramatically changing the way we manage our personal health and everyday wellness.

read more
open full screen

Generation and Application of Community Pharmacy Research

Neil Johnston

Editor’s Note: We have had a number of articles in this issue relating to pharmacy research.
The PGA has conducted a number of research initiatives over the years, including one recently reported in Pharmacy News that resulted from an analysis of the QCPP Patient Questionnaire.
Pharmacy Guild president, George Tambassis, appears to have authored the article following, and there also appears to be a disconnect between the survey report and its target audience illustrated by one of the respondent comments published.
I have asked Mark Coleman to follow through, elaborate and comment:

read more
open full screen

Is This Fraud Too Big Even For 60 Minutes?

Staff Researcher

articles by this author...

Editing and Researching news and stories about Australian and International Pharmacy Issues

We are republishing the article below, written by Dr Joseph Mercola.
It reveals the extent to which medical fraud has become systemic and commonplace.
The people that do original research and have it published are in the main, medical academics - similar to the medical academics that have joined together under the Friends of Science in Medicine (FSM) banner which is lobbying to have complementary-based science courses banned at universities.
While we are not suggesting that any of the members of this group have been involved in medical fraud, we do find it strange that their agenda does not include putting their own house in order first, to illustrate a lack of bias and a willingness to lead by example.
This would create a level of support for the cause from all health practitioners because we all want to do "what is right".
Certainly they would present as a more credible organisation if this was the case, rather than a group that is trying to get "points on the board" by pursuing the stated soft targets (chirporacters, naturopaths etc), because they are not the real problem.
Professionally we all allow ourselves to be bound by "evidenced-based medicine".
But what happens when significant components of that evidence (up to 50% according to Dr John Ioannidis mentioned in the Mercola article) is corrupt and unable to be relied upon.

What happens then?

open this article full screen

Personally I would prefer FSM to specify their evidence and prove their case after cleansing their own environment first.
It is not enough to say that these alternate sciences are not based on evidence, because in many instances they are treatments waiting for evidence to catch up with the results achieved by their practitioners, or the evidence exists but it is not published in the medical journals that are controlled medically.
In all the debates on evidence we consistently see a large slab of positive effect attributed to "placebo". Why then is it so difficult to accept that placebo equals evidence of genuine care.

As a member of an orthodox health discipline I consistently observe so called evidence-based medicines not performing as claimed. Have we a mechanism to report this type of problem?
We can report adverse events but not drugs that don't work.
And how did the evidence get accepted in the first place?
There is something very wrong with the methodology for developing, recording and testing evidence as other writers in this publication have found
Meanwhile, the only credible evidence I personally have left to rely on is my own experience, and I will continue to rely on that for the safety of my own patients- regardless of what the various agencies and self-appointed gatekeepers have to say. 

 

Exposure and subsequent concern over medical research fraud is on the rise, and for good reason.

It's now reached the point where blogs exist solely to cover retractions of published researchi.

An episode of 60 Minutes, featured above, also highlights the problem.

In this episode, they reveal the dramatic rise and fall of Dr. Anil Potti, whose cancer research at Duke University was heralded as a groundbreaking game changer.

It's a perfect example of how fraud can occur anywhere. Even at the best institutions.

Dr. Potti's work, which entailed matching a patient's tumor to the best chemotherapy drug based on its DNA makeup, was the most exciting cancer breakthrough in recent history, according to many involved.

More than 100 cancer-stricken and desperate patients signed up for Dr. Potti's trial. Unfortunately, two years ago, it became apparent that the method was a failure. Not only that, but as stated in the 60 Minutes segment, Dr. Potti's discovery "may end up being one of the biggest medical research frauds ever; one that deceived dying patients, the best medical journals, and a great University."

Dr. Potti May have Faked Both Credentials and Research Data

Questions about Dr. Potti's research had been raised, but were cleared by a committee at Duke University. It wasn't until a confidential source tipped off the editor of The Cancer Letter to take another look at Dr. Potti's claim of being a Rhodes Scholar that the lies began unraveling.

Joseph Nevins, Dr. Potti's mentor and coworker at Duke University for over four years confronted him about the accusation he may have lied on his resume. Potti admitted that he wasn't really a Rhodes Scholar, rather it was a fellowship from Rhodes Scholars in Australia... Nevins decided to take another look at Dr. Potti's original data, eventually concluding that it was "abundantly clear" Potti had purposefully manipulated the data.

Whenever the data disproved Potti's theory, the data had simply been altered.

The claim that the novel procedure had an 80 percent chance of success was a complete lie, and patients in Potti's trial died. Some of the surviving family members are now suing. Dr. Potti has stated that he "... was not aware that false or 'improper' information had been included in the research." Duke University has also apologized for the trials, and has opened up about the case to serve as a warning example to other institutions.

But the greatest irony of all is brought up at the very end of the 60 Minutes' segment. While patients did not receive any groundbreaking treatment, Duke University has stated that none of the patients in Dr. Potti's failed trial were really harmed "because all of them received the standard of care in chemotherapy."

And THAT, my friends, is the real "Biggest Medical Fraud" of all time.

It's so big, 60 Minutes will not likely discuss that truth any time soon. In reality, virtually the entire cancer industry is one massive fraud, in the sense that it's not really allowing authentic and inexpensive cancer cures that address the cause of the problem to come to market. They are virtually all violently opposed and condemned. It's a massive for-profit industry, and unless a treatment revolves around a costly drug that can be patented, it will never see the light of day. The whole idea that the cancer industry is "searching for a cure" is a sham... because cures already exist. But they're being massively suppressed.

Why Many Groundbreaking Cancer Therapies are Suppressed

It's kind of sad to hear how Dr. Potti's idea of using DNA-matching to customize treatments created such waves of excitement, knowing that similar gene-target therapies have been vehemently suppressed, simply because they did not involve expensive pharmaceuticals patented by Big Pharma.

Burzynski: The Movie tells the story of Dr. Stanislaw Burzynski, who developed a non-toxic gene-target cancer therapy called antineoplastons, and has been harassed by the Food and Drug Administration (FDA) for over 14 years in an effort to shut him down. His treatment could have helped save millions of lives over the last two decades had his discovery not been criminally suppressed by the U.S. government, as it has been shown to effectively help cure some of the most "incurable" forms of terminal cancer. The film is a powerful expose of the unscrupulous forces that work to maintain the status quo of the medical and pharmaceutical industry at any cost.

Why was Dr. Burzynski attacked while Dr. Potti was worshipped as a wunderkind?

Potti was working within "the standard of care," matching chemotherapy drugs to the DNA of patient's tumors, while Burzynski's antineoplastons are non-toxic peptides and derivatives of amino acids that work as genetic switches. In short, Dr. Burzynski developed a cancer treatment that surpassed all other treatments on the market, and the FDA, the pharmaceutical industry, and the National Cancer Institute all knew it. But he was also the sole owner of the patents for this therapy, and these two facts combined threatened the entire paradigm of the cancer industry.

The cancer paradigm is based on very expensive machines and toxic drugs. There's an enormous amount of money to be made in this paradigm, no one in the cancer industry, aside from Burzynski himself, stand to make a dime if his treatment is granted approval and goes mainstream. That's why it has been suppressed, despite the fact that antineoplastons have been shown to be far more effective than the current standard of care. The film features several remarkable case stories of people who were successfully cured of cancer, but it's when the clinical trial data of conventional therapies versus antineoplastons are stacked against each other that the benefits of antineoplastons become really obvious:

Radiation or Chemotherapy Only

* 5 of 54 patients (9 percent)were cancer free at the end of treatment

* Toxic side effects

Antineoplastons Only

* 5 of 20 (25 percent)were cancer free at the end of treatment

* No toxic side effects

 

 

Systemic Corruption within the FDA Threatens Your Health

Unfortunately, our government plays a significant and ongoing role in the committing of this kind of scientific fraud. I recently commented on the fact that the FDA secretly monitored the personal e-mail of nine whistleblowers—its own scientists and doctors—over the course of two years. The whistleblowers, who worked in the office responsible for reviewing medical devices, including those for cancer screening, had warned Congress that the agency was approving medical devices that posed unacceptable risks to patients.

Jeffrey Shuren, director of the FDA's Center for Devices and Radiological Health kept pushing for the Department of Health and Human Services' (DHHS) inspector general to investigate the employees, accusing them of improperly disclosing confidential business information about the devices.

Shuren is also the official who oversees mercury dental fillings, which they have been fraudulently referring to as 'silver fillings'. He had promised to make an announcement about dental amalgam by the end of 2011. But with just six minutes left in the work year, at 4:54 pm on Friday, December 30, the FDA conceded that no announcement was forthcoming – not in 2011, and maybe not at all.

I've long questioned the safety of mammography, based on compelling information from scientists and experts in the field. Here, we have a number of FDA employees warning Congress that the agency is placing patient's lives at risk, due to internal corruption... and still nothing is done.

The fact is, a lot of what the general public assumes is "science-based medicine" is anything but. According to one recent poll for the British Medical Journal, one in 10 scientists and doctors claim to have witnessed colleague's deliberately fabricating data in order to get their research publishedii. Back in 2005, Dr. John Ioannidis, an epidemiologist at Ioannina School of Medicine, Greece, showed that there is less than a 50 percent chance that the results of any randomly chosen scientific paper will be true! He repeated his investigation in 2008 and found that much of scientific research being published is highly questionable. According to his study:

"Simulations show that for most study designs and settings, it is more likely for a research claim to be false than true."

Add to that the fact that the FDA is not doing its stated job either, and it should be quite clear that there's really no one out there protecting your health from dangerous pharmaceuticals and medical treatments...

Notable Cases of Medical Fraud

While many believe Dr. Potti may go down as the largest medical science fraud case in modern history, we've seen several stunning cases in the last few years. Tragically, some if not all of them may have contributed to significant health ramifications and loss of life of many thousands of people:

Scott S. Reuben, a prominent Massachusetts anesthesiologist, allegedly fabricated 21 medical studies published between 1996 and 2008 that claimed to show benefits from painkillers like Vioxx, Celebrex, Bextra and Lyrica. His work was considered important in encouraging doctors to combine the use of painkillers like Celebrex and Lyrica for patients undergoing common procedures such as knee and hip replacementsLast year, autism researcher Poul Thorsen was charged with 13 counts of wire fraud and nine counts of money laundering. He also allegedly stole over $1 million from autism research funding between February 2004 and June 2008. He is said to have stolen the money while serving as the 'principal investigator' for a program that studied the relationship between autism and exposure to vaccines. He was involved in several key studies the CDC uses to support their claims that MMR and mercury-containing vaccines, among others, are safe. One of his papers on the subject, known as 'The Danish Study', is extensively quoted to refute the autism-vaccine connectionIn October, 2011, the Office of Research Integrity at the U.S. Department of Health discovered that a Boston University cancer scientist,Sheng Wang, had fabricated his research findings. His work was published in two journals in 2009, and he's been ordered to retract them. But important studies by other scientists like those at the Mayo Clinic, who based their work on his findings, could now see 10 years of their studies going down the drain as worthless...In November of last year, a noted Dutch psychologist confessed to fabricating research data for years. According to an investigating committee, Dr. Diederik Stapel falsified entire experiments, and several dozen of his fabricated papers were published in respected psychology journals and promoted in the mediaiii.In January, resveratrol researcher with the University of Connecticut, Dipak Das, was found guilty of 145 counts of fabrication and falsification of data published in 11 different journals.iv

How to Get Solid Information in an Era of Confusion

Ultimately, my take-home message here is that even if a drug or treatment is scientifically proven, all these examples make it crystal clear that this simply is not a guarantee of safety or effectiveness. Likewise, if an alternative treatment has not been published in a medical journal, it does not mean it is unsafe or ineffective. There's a lot to be said for the tried-and-true remedies of old, even if they've not been rigorously studied by modern researcher.

I recommend using all the resources available to you, including your own sense of common sense and reason, true experts' advice and other's experiences, to determine what medical treatment or advice will be best for you in any given situation. Remain skeptical but open -- even if it is something I am saying, you simply need to realize YOU are responsible for your health, not me and certainly not drug companies trying to sell their wares.

Seeing how it's been well established that most drugs do absolutely nothing to treat the cause of disease, it would be prudent to exercise the precautionary principle when evaluating ANY new drug claim, as it will more than likely be seriously flawed or biased -- and is most likely not in your long-term best interest.

If you're facing a health challenge, I recommend seeking out a qualified natural health consultant. A good place to look for recommendations is at your local health food store. Get to know the people who work there, the owners, and those who frequent the store, and obtain a consensus as to who the best clinician for you is in your area. Word travels fast in the natural medical community, so if there's a knowledgeable practitioner in your area that's getting awesome results, his or her reputation will be known. Of course, when it comes to cancer, you'll want to identify someone that is well known and respected for their work in treating cancer patients. If you don't find one locally then scour the Internet and make calls to plenty of patients that the practitioner has seen.

References:

i Retraction Watch
ii Daily Mail, January 12, 2012
iii Fraud Case Seen as a Red Flag for Psychology Research, The New York Times, November 3, 2011
iv Hold Off On That Glass Just Yet – Red Wine Researcher Charged With Falsifying Data, Singularityhub.com, January 15, 2012

Return to home

Submitted by Peter Kennedy on Fri, 16/03/2012 - 07:01.

My oh my, you have published some outrageously false and misleading articles in your ongoing campaign to try to convince pharmacists that so-called "alternative" medicine" is better than scientifically based medicine, but you are really scrapping the bottom of the barrel here. Even if all of your scurrilous assertions were true, scintific based medicine would still be infinitely preferable to "medicine" which is INHERENTLY useless because its prtended basis is not even logically defensible or plausible in theory, much less in practice.
No wonder you don't even have the guts to put your name to this piece of garbage.

Post new comment

The content of this field is kept private and will not be shown publicly.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Allowed HTML tags: <a> <em> <strong> <cite> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Lines and paragraphs break automatically.

More information about formatting options

health news headlines provided courtesy of Medical News Today.

Click here to read more...

If any difficulty is found in subscribing, please use the "Contact Us" panel found in the navigation bar with the message "subscribe" and your email address.

Subscribe to our mailing list

Email Format
 

 

  • Copyright (C) 2000-2020 Computachem Services, All Rights Reserved.

Website by Ablecode